GHR and amyotrophic lateral sclerosis: The results have demonstrated that tested treatments had motor neuron protective actions and suppressed muscular weakness and strength reduction, suggesting that a pharmaceutical composition comprising a GHS receptor agonist can be a potential therapeutic agent for ALS.